Literature DB >> 12939397

pRb inactivation in senescent cells leads to an E2F-dependent apoptosis requiring p73.

Kamilah Alexander1, Hai-Su Yang, Philip W Hinds.   

Abstract

Senescent cells in which pRb is inactivated undergo apoptosis on attempted reinitiation of DNA synthesis. To further explore the cell death resulting from loss of pRb function in senescent cells, we employed a temperature-sensitive pRb mutant protein (tspRb). We found that tspRb inactivation results in rapid E2F reactivation and subsequent S-phase reentry associated with the up-regulation of E2F target gene expression and cyclin E-dependent kinase activity. Total inhibition of cyclin-dependent kinase 2 activity results in a cell cycle arrest on pRb loss and a nearly complete suppression of apoptosis. Furthermore, blocking of E2F activity with a dominant-negative DP1 inhibits S-phase reentry and cell death following tspRb inactivation. Finally, inhibition of p73 activity abolishes apoptosis but not S-phase entry on pRb inactivation, suggesting that activation of E2F in senescent cells can result in the use of p73 as a cell death effector. Interestingly, senescent cells rescued from apoptosis maintain their altered shape and express senescence-associated beta-galactosidase despite loss of pRb function. Thus, maintenance of the terminal cell cycle arrest of senescent cells requires continuous pRb-mediated inactivation of E2F activity, the reappearance of which in these irrevocably altered cells triggers a cell death program instead of an inappropriate resumption of cell cycling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939397

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

Review 1.  Cellular senescence in cancer treatment: friend or foe?

Authors:  Pascal Kahlem; Bernd Dörken; Clemens A Schmitt
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

3.  Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Elizabeth E Jones; Kristen B Habash; Hiroshi Matsuo; Susanne I Wells
Journal:  Mol Cell Biol       Date:  2006-08-07       Impact factor: 4.272

Review 4.  What has senescence got to do with cancer?

Authors:  Goberdhan P Dimri
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

5.  Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.

Authors:  Hai-Xia Qin; Ke-Jun Nan; Guang Yang; Zhao Jing; Zhi-Ping Ruan; Chun-Li Li; Rui Xu; Hui Guo; Chen-Guang Sui; Yong-Chang Wei
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 6.  Tumor suppression by p53: making cells senescent.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Histol Histopathol       Date:  2010-04       Impact factor: 2.303

7.  Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice.

Authors:  Ae Rin Baek; Jisu Hong; Ki Sung Song; An Soo Jang; Do Jin Kim; Su Sie Chin; Sung Woo Park
Journal:  Exp Mol Med       Date:  2020-12-14       Impact factor: 8.718

8.  Estrogen Signaling Induces Mitochondrial Dysfunction-Associated Autophagy and Senescence in Breast Cancer Cells.

Authors:  Khuloud Bajbouj; Jasmin Shafarin; Jalal Taneera; Mawieh Hamad
Journal:  Biology (Basel)       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.